| Website | cytopherx.com |
| Category | Consumer Electronics/Devices |
| Phone | 734.272.4772 |
| Employees |
| TOTAL | $34M |
| FUNDING TOTAL | $34M |
| Venture Round, 1/12 Early Stage Partners ONSET Ventures Capital Midwest Fund Kaiser Permanente Ventures Emergent Medical Partners Aphelion Capital Lurie Investment Fund | $34M |
CytoPherx, Inc., founded in July 2007 and headquartered in Ann Arbor, Michigan, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.
The Company’s products are custom, patent-protected configurations of commercially available hollow fiber dialysis filters that are used in a proprietary manner to sequester and deactivate leukocytes in the patient’s blood system. The Company is initially focused on acute renal failure (ARF).
